Global DNA methylation market size reached USD 7.79 billion in 2021 and is expected to register a revenue CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research. Rising usage of DNA methylation technology in oncology research is expected to drive market revenue growth between 2022 and 2030
Increasing prevalence of cancers and various other conditions has led to increased adoption of DNA methylation which is expected to further drive market revenue growth during the forecast period. DNA methylation technology has been adopted in various research initiatives and techniques such as DNA sequencing, genome-wide and gene-specific analyses, and others, which makes it one of the promising technologies in molecular biology.
The report studies the factors influencing the growth of the industry in the global market and offers accurate predictions about the growth pattern. The report pays special attention to the key elements of the market, such as drivers, restraints, opportunities, threats, risks, limitations, and other aspects. The report covers a comprehensive analysis of the competitive landscape with a detailed analysis of the company profiles, product portfolio, and business expansion strategies.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/1006
Some Key Highlights From the Report
DNA sequencing segment revenue is expected to register a substantially rapid CAGR during the forecast period due to rising usage of DNA methylation in DNA sequencing analyses such as pyro-sequencing and Illumina sequencing.
Bisulfite DNA modification segment is expected to account for largest revenue share over the forecast period due to rapid growth of the biotechnology industry.
Enzymes segment revenue is expected to register a substantially rapid CAGR during the forecast period due to rising usage of enzymes in DNA methylation reactions during DNA sequencing analyses, such as pyro-sequencing and Illumina sequencing.
Asia Pacific DNA methylation market is expected to register a steady revenue growth rate over the forecast period due to the rapid growth of the pharmaceutical industry in countries in the region. Rising awareness regarding usage of DNA methylation as a promising diagnostic test in clinical research is another factor expected to drive market growth.
Some major companies in the global market report include New England Biolabs, Merck KGaA, Pacific Biosciences, Inc., Thermo-Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, Abcam plc., F. Hoffmann-La Roche Ltd., and Diagenode Diagnostics S.A.
Emergen Research has segmented the global DNA methylation market on the basis of technology, application, end-use, and region:
Technology Outlook (Revenue, USD Billion, 2019–2030)
Bisulfite DNA Modification
Methylated DNA Immunoprecipitation
High-Resolution Melt Analysis
Others
Application Outlook (Revenue, USD Billion, 2019–2030)
DNA Sequencing
Oncology Research
Microarray
Immunological Assays
Others
End-Use Outlook (Revenue, USD Billion, 2019–2030)
Biotechnology Industry
Pharmaceutical Industry
Academic Institutions
Research Laboratories
Others
Product Outlook (Revenue, USD Billion, 2019–2030)
Enzymes
Reagents
Kits
Instruments and Consumables
Others
Dna Methylation Key Coverage of report:
Dna Methylation Market share valuations of the segments on a country and global level.
Dna Methylation Market share analysis of the major market players.
Opportunities and growth prospects for the new Dna Methylation 7 market entrants.
Dna Methylation Market forecast for all the segments, sub-segments of the market.
Dna Methylation Market Trends (drivers, restraints, opportunities, challenges, threats, investment opportunities, and approvals)
Strategic endorsements in the key business segments on the basis of Dna Methylation market valuations.
Competitive landscape mapping of the key development patterns.
Company profiling with detailed strategies, financial details, and recent developments.
Latest supply chain trends and technological advancements.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/1006
The report objectives are:
To evaluate Dna Methylation status, future forecast, growth opportunity, key market, and key players.
To present the Global Dna Methylation development in the different regions of the world.
To strategically study and segment the key players and comprehensively analyze their development plan and strategies.
To define, describe, and forecast the market by product type, market, and key regions.
Overview of the Dna Methylation Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the Dna Methylation industry
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East Africa.
Read More: https://www.emergenresearch.com/industry-report/dna-methylation-market
Related Reports:
microfluidics market
craniomaxillofacial devices market
radiotherapy market
pediatric psoriasis market
biologics market
clinical decision support systems market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
